Treatment of Orthostatic Hypotension

Seminars in Neurology

Volumn 23, Issue 4, 2003, Pages 435-442

  Freeman, Roy ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Autonomic failure; Autonomic nervous system; Orthostatic hypotension; Postural hypotension; Sympathetic nervous system

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CARBIDOPA; CHOLINESTERASE INHIBITOR; CLONIDINE; DESMOPRESSIN ACETATE; DEXAMPHETAMINE; DIHYDROERGOTAMINE; DIHYDROXYPHENYLSERINE; DOMPERIDONE; DOPAMINE RECEPTOR BLOCKING AGENT; EPHEDRINE; FLUDROCORTISONE; HYDROCORTISONE DERIVATIVE; METHYLPHENIDATE; METOCLOPRAMIDE; MIDODRINE; NORADRENALIN; PHENYLPROPANOLAMINE; PHENYLSERINE; PROSTAGLANDIN SYNTHASE INHIBITOR; PSEUDOEPHEDRINE; PYRIDOSTIGMINE; RECOMBINANT ERYTHROPOIETIN; SODIUM CHLORIDE; SOMATOSTATIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASOPRESSIN; YOHIMBINE;

ABDOMINAL CRAMP; ANKLE EDEMA; ANXIETY DISORDER; AUTONOMIC DYSFUNCTION; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DEGENERATIVE DISEASE; DIARRHEA; EXTRAPYRAMIDAL SYMPTOM; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; HYPOKALEMIA; NAUSEA; NORADRENALIN RELEASE; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; POTASSIUM INTAKE; PRIORITY JOURNAL; SALT INTAKE; SEDATION; SHY DRAGER SYNDROME; SYMPTOMATOLOGY; TACHYPHYLAXIS; TARDIVE DYSKINESIA; TREMOR; XEROSTOMIA;

ANIMALS; BLOOD VOLUME; HUMANS; HYPOTENSION, ORTHOSTATIC; POSTURE; SYMPATHOMIMETICS;

EID: 1842564102     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-817727     Document Type: Conference Paper

References (63)

1. Borst C, Weiling W, van Brederode JFM, et al. Mechanisms of initial heart rate response to postural change. Am J Physiol 1982;243:H676-H681
2. Smit AA, Halliwill JR, Low PA, Wieling W. Pathophysiological basis of orthostatic hypotension in autonomic failure. J Physiol 1999;519(Pt 1):1-10
3. Position paper. Orthostatic hypotension, multiple system atrophy (the Shy Drager syndrome) and pure autonomic failure. J Auton Nerv Syst 1996;58:123-124
4. Goldstein DS, Polinsky RJ, Garty M, et al. Patterns of plasma levels of catechols in neurogenic orthostatic hypotension. Ann Neurol 1989;26:558-563
5. Goldstein DS, Holmes C, Sharabi Y, Brentzel S, Eisenhofer G. Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension. Neurology 2003;60:1327-1332
6. Omboni S, Smit AA, van Lieshout JJ, Settels JJ, Langewouters GJ, Wieling W. Mechanisms underlying the impairment in orthostatic tolerance after nocturnal recumbency in patients with autonomic failure. Clin Sci (Lond) 2001;101: 609-618
7. van Lieshout JJ, ten Harkel AD, Wieling W. Physical manoeuvres for combating orthostatic dizziness in autonomic failure. Lancet 1992;339:897-898
8. Wieling W, van Lieshout JJ, van Leeuwen AM. Physical manoeuvres that reduce postural hypotension in autonomic failure. Clin Auton Res 1993;3:57-65
9. Shannon J, Jordan J, Costa F, Robertson RM, Biaggioni I. The hypertension of autonomic failure and its treatment. Hypertension 1997;30:1062-1067
10. Shannon JR, Jordan J, Diedrich A, et al. Sympathetically mediated hypertension in autonomic failure. Circulation 2000; 101:2710-2715
11. MacLean AR, Allen BV. Orthostatic hypotension and orthostatic tachycardia. Treatment with the "head-up" bed. JAMA 1940;115:2162-2167
12. Jordan J, Shannon JR, Black BK, et al. The pressor response to water drinking in humans: a sympathetic reflex? Circulation 2000;101:504-509
13. Campbell IW, Ewing DJ, Clarke BF. 9-Alpha-fluorohydro-cortisone in the treatment of postural hypotension in diabetic autonomic neuropathy. Diabetes 1975;24:381-384
14. Hickler RB, Thompson GR, Fox LM, Hamlin JT. Successful treatment of orthostatic hypotension with 9-alpha-fluorohydrocortisone. N Engl J Med 1959;261:788-791
15. Schatz IJ, Miller MJ, Frame B. Corticosteroids in the management of orthostatic hypotension. Cardiology 1976;61 (Suppl. 1):280-289
16. van Lieshout JJ, ten Harkel AD, Wieling W. Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure. Clin Auton Res 2000;10:35-42
17. Chobanian AV, Volicer L, Tifft CP, Gavras H, Liang CS, Faxon D. Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. N Engl J Med 1979;301:68-73
18. Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, doubleblind multicenter study. Midodrine Study Group. JAMA 1997;277:1046-1051
19. Kaufmann H, Brannan T, Krakoff L, Yahr MD, Mandeli J. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine). Neurology 1988;38:951-956
20. Wright RA, Kaufmann HC, Perera R, et al. A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology 1998;51:120-124
21. Jordan J, Shannon JR, Biaggioni I, Norman R, Black BK, Robertson D. Contrasting actions of pressor agents in severe autonomic failure. Am J Med 1998;105:116-124
22. Ghrist DG, Brown GE. Postural hypertension with syncope: its successful treatment with ephedrine. Am J Med Sci 1928; 175:336-349
23. Davies B, Bannister R, Sever P. Pressor amines and monoamine-oxidase inhibitors for treatment of postural hypotension in autonomic failure. Limitations and hazards. Lancet 1978;1:172-175
24. Biaggioni I, Onrot J, Stewart CK, Robertson D. The potent pressor effect of phenylpropanolamine in patients with autonomic impairment. JAMA 1987;258:236-239
25. Freeman R. Treatment of orthostatic hypotension: Midodrine and other pressor drugs. In: Robertson D, Low PA, Polinsky RJ, eds. Primer on the Autonomic Nervous System. New York: Academic Press; 1996:326-332
26. Fouad-Tarazi FM, Okabe M, Goren H. Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension. Am J Med 1995;99:604-610
27. Kernan WN, Viscoli CM, Brass LM, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med 2000;343:1826-1832
28. Kaufmann H, Oribe E, Miller M, Knott P, Wiltshire-Clement M, Yahr MD. Hypotension-induced vasopressin release distinguishes between pure autonomic failure and multiple system atrophy with autonomic failure. Neurology 1992;42:590-593
29. Ozawa T, Oyanagi K, Tanaka H, et al. Suprachiasmatic nucleus in a patient with multiple system atrophy with abnormal circadian rhythm of arginine-vasopressin secretion into plasma. J Neurol Sci 1998;154:116-121
30. Mathias CJ, Fosbraey P, da Costa DF, Thornley A, Bannister R. The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure. Br Med J (Clin Res Ed) 1986; 293:353-354
31. Sakakibara R, Matsuda S, Uchiyama T, Yoshiyama M, Yamanishi T, Hattori T. The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria. Clin Auton Res 2003;13: 106-108
32. Biaggioni I, Robertson D, Krantz S, Jones M, Haile V. The anemia of primary autonomic failure and its reversal with recombinant erythropoietin. Ann Intern Med 1994;121:181-186
33. Winkler AS, Marsden J, Parton M, Watkins PJ, Chaudhuri KR. Erythropoietin deficiency and anaemia in multiple system atrophy. Mov Disord 2001;16:233-239
34. Winkler AS, Landau S, Watkins P, Chaudhuri KR. Observations on haematological and cardiovascular effects of erythropoietin treatment in multiple system atrophy with sympathetic failure. Clin Auton Res 2002;12:203-206
35. Rao SV, Stamler JS. Erythropoietin, anemia, and orthostatic hypotension: the evidence mounts. Clin Auton Res 2002;12: 141-143
36. Hoeldtke RD, Streeten DHP, Streeten DH. Treatment of orthostatic hypotension with erythropoietin. N Engl J Med 1993;329:611-615
37. Perera R, Isola L, Kaufmann H. Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure. Clin Auton Res 1995;5:211-213
38. Onrot J, Goldberg MR, Biaggioni I, Hollister AS, Kingaid D, Robertson D. Hemodynamic and humoral effects of caffeine in autonomic failure. Therapeutic implications for postprandial hypotension. N Engl J Med 1985;313:549-554
39. Robertson D, Goldberg MR, Hollister AS, Wade D, Robertson RM. Clonidine raises blood pressure in idiopathic orthostatic hypotension. Am J Med 1983;74:193-199
40. Robertson D, Goldberg MR, Tung CS, Hollister AS, Robertson RM. Use of alpha 2 adrenoreceptor agonists and antagonists in the functional assessment of the sympathetic nervous system. J Clin Invest 1986;78:576-581
41. Onrot J, Goldberg MR, Biaggioni I, Wiley RG, Hollister AS, Robertson D. Oral yohimbine in human autonomic failure. Neurology 1987;37:215-220
42. Mehlsen J, Trap-Jensen J. Xamoterol, a new selective beta-1-adrenoceptor partial agonist, in the treatment of postural hypotension. Acta Med Scand 1986;219:173-177
43. Obara A, Yamashita H, Onodera S, Yahara O, Honda H, Hasebe N. Effect of xamoterol in Shy-Drager syndrome. Circulation 1992;85:606-611
44. West JN, Stallard TJ, Dimmitt SB, Smith SA, Williams A, Littler WA. Xamoterol in the treatment of orthostatic hypotension associated with multiple system atrophy (Shy-Drager syndrome). Q J Med 1990;74:209-213
45. Cleophas TJ, Grabowsky I, Niemeyer MG, Makel WM, van der Wall EE. Paradoxical pressor effects of beta-blockers in standing elderly patients with mild hypertension: a beneficial side effect. Circulation 2002;105:1669-1671
46. Chobanian AV, Volicer L, Liang CS, Kershaw G, Tifft C. Use of propranolol in the treatment of idiopathic orthostatic hypotension. Trans Assoc Am Physicians 1977;90:324-334
47. Man in't Veld AJ. Schalekamp MA. Pindolol acts as beta-adrenoceptor agonist in orthostatic hypotension: therapeutic implications. Br Med J (Clin Res Ed) 1981;282:929-931
48. Leslie PJ, Thompson C, Clarke BF, Ewing DJ. A doubleblind crossover study of oral xamoterol in postural hypotension due to diabetic autonomic neuropathy. Clin Auton Res 1991;1:119-123
49. Hoeldtke RD, Israel BC. Treatment of orthostatic hypotension with octreotide. J Clin Endocrinol Metab 1989;68: 1051-1059
50. Hoeldtke RD, Horvath GG, Bryner KD, Hobbs GR. Treatment of orthostatic hypotension with midodrine and octreotide. J Clin Endocrinol Metab 1998;83:339-343
51. Freeman R, Landsberg L, Young J. The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine: a randomized, placebo-controlled, crossover trial. Neurology 1999;53:2151-2157
52. Mathias CJ, Senard JM, Braune S, et al. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure. Clin Auton Res 2001;11:235-242
53. Kaufmann H, Saadia D, Voustianiouk A, et al. Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Circulation 2003;108:724-728
54. Freeman R, Young JB, Landsberg L, Lipsitz LA. The treatment of postprandial hypotension in autonomic failure with 3,4-DL-threo-dihydroxyphenylserine. Neurology 1996;47: 1414-1420
55. Hoeldtke RD, Cavanaugh ST, Hughes JD, Polansky M. Treatment of orthostatic hypotension with dihydroergotamine and caffeine. Ann Intern Med 1986;105:168-173
56. Fouad FM, Tarazi RC, Bravo EL. Dihydroergotamine in idiopathic orthostatic hypotension: short-term intramuscular and long-term oral therapy. Clin Pharmacol Ther 1981;30: 782-789
57. Jennings G, Esler M, Holmes R. Treatment of orthostatic hypotension with dihydroergotamine. BMJ 1979;2:307
58. Biaggioni I, Zygmunt D, Haile V, Robertson D. Pressor effect of inhaled ergotamine in orthostatic hypotension. Am J Cardiol 1990;65:89-92
59. Watt SJ, Tooke JE, Perkins CM, Lee MR. The treatment of idiopathic orthostatic hypotension: a combined fludrocortisone and flurbiprofen regime. Q J Med 1981;50:205-212
60. Kochar MS, Itskovitz HD. Treatment of idiopathic orthostatic hypotension (Shy-Drager syndrome) with indomethacin. Lancet 1978;1:1011-1014
61. Lopes de Faria SR, Zanella MT, Andriolo A, Ribeiro AB, Chacra AR. Peripheral dopaminergic blockade for the treatment of diabetic orthostatic hypotension. Clin Pharmacol Ther 1988;44:670-674
62. Magnifico F, Pierangeli G, Barletta G, et al. The cardiovascular effects of metoclopramide in multiple system atrophy and pure autonomic failure. Clin Auton Res 2001;11:163-168
63. Singer W, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Bharucha AE, Low PA. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry 2003;74:1294-1298